Initial experience with use of hydrogel microcoils in embolization of pulmonary arteriovenous malformations

Keigo Osuga1, Kentaro Kishimoto1, Kaishu Tanaka1

  • 1Department of Diagnostic and Interventional Radiology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871 Japan.

Springerplus
|May 2, 2015
PubMed

Insights

Hydrogel microcoils offer a safe and effective method for embolizing pulmonary arteriovenous malformations (PAVMs). This study shows significant shrinkage of PAVMs treated with these innovative coils.

Area of Science:

  • Interventional Radiology
  • Vascular Medicine
  • Medical Device Technology

Background:

  • Pulmonary arteriovenous malformations (PAVMs) are abnormal connections between pulmonary arteries and veins.
  • Embolization is a common treatment for PAVMs, but coil selection can impact outcomes.
  • Hydrogel microcoils represent a newer option for PAVM embolization.

Purpose of the Study:

  • To evaluate the initial clinical experience with hydrogel microcoils for PAVM embolization.
  • To assess the technical and radiological outcomes of using hydrogel microcoils in patients with PAVMs.

Main Methods:

  • Retrospective review of seven patients with nine simple-type PAVMs.
  • Embolization performed using primarily hydrogel microcoils, supplemented with detachable bare microcoils.
  • Analysis of coil deployment success, complications, and PAVM size reduction post-treatment.

Main Results:

  • Hydrogel microcoils were successfully deployed in 8/9 PAVMs without complications.
  • A significant median size reduction of 95.0% was observed in PAVMs treated with hydrogel microcoils.
  • One PAVM treated solely with bare microcoils showed recanalization, requiring a second procedure.

Conclusions:

  • Hydrogel microcoils are safe and effective for embolizing PAVMs, particularly those with smaller feeding arteries.
  • Successful deployment and substantial PAVM shrinkage were achieved using hydrogel microcoils.
  • Hydrogel microcoils demonstrate promising results as an alternative embolic agent for PAVMs.

Related Concept Videos